Go to content
Home
Sections
Search
Topics per section
About MEB
Column by the chairman: 'On medicines'
Cooperation in Europe
Cooperation in the Netherlands
Integrity, openness and finances
MEB Advisory Board
Our story: Good medicines used better
Our tasks
Science
The Agency
The Board
Working at the MEB
Marketing authorisation medicines for human use
Animal testing
Application procedure advisory meetings
Authorisation Contact Committee (CCR)
Biosimilar medicinal product
Centralised procedure
Compassionate use programme
Consultation procedure for medical devices
Correspondence during procedure
Cover letter
Decentralised procedure
Decision-making process at the European level
Direct Healthcare Professional Communication (DHPC)
Dossier modules
Duplex marketing authorisation
EudraVigilance signal management pilot
Falsified Medicines Directive
Fees and product types
Generic medicinal product
GMP and quality defects
Homeopathic medicinal product
Implementation of agreed wording
Informed consent
Labelling
Legal status of supply
Marketing authorisation for reasons of public health
Marketing authorisations without Dutch translations of the product information and/or mock-ups
Marketing discontinuation, suspension and shortages
MEB policy documents
Medicinal gas marketing authorisation
Medicine pictograms
Mutual recognition procedure
National contact person for pharmacovigilance
National procedure
New active substance
Nomenclature, excipients, abbreviated indications
Package leaflet
Paediatric medicinal product
Parallel import
Parallel procedures: faster assessment of medicines
Patented indication
Periodic safety update reports (PSUR)
Pipeline meetings
Planning tool for application procedures
Proposed withdrawals and patients' interest
QR code
QRD templates
Renewal
Reporting adverse events
Reporting adverse events during clinical trials
Responsibilities following marketing authorisation
Risk management plan
Scientific and regulatory advice
Site clearance
Submission via CESP
Summary of product characteristics (SmPC)
Technical validation
Temporarily supply of a medicinal product in a different packaging
Traditional herbal medicinal product
TSE requirements
Variation
Well established use
Withdrawal of a marketing authorisation
Veterinary medicines
Advertising
Animal feed additives
Animal feed claims
Application procedures
Cascade
Certificates
Clinical trial with a veterinary medicinal product
Committee for the Authorisation of Veterinary Medicines (Ctd)
Committee on the authorisation of veterinary medicinal products
Database for manufacturing and wholesale distribution (EudraGMDP)
Dietetic feeds
Export of veterinary medicinal products
Feed materials
Fees and product types Veterinary Medicinal Products Unit
Good distribution practice (GDP)
Homeopathic veterinary medicinal product
Inspection
Internet trade in veterinary medicinal products
Legal status of supply
Legislation on veterinary medicinal products
Licence requirements for retail (D)
Licence requirements for wholesale (G)
Licence types
Manufacturing (F) (GMP)
Marketing authorisation exemption
Opium Act and veterinary medicinal products
Organisation Management Service (OMS)
Parallel distribution
Parallel trade in veterinary medicinal products
Permission to carry out tests with additives for animal feed
Pharmacovigilance communication plan
Production and/or distribution licence application, change or withdrawal
PSMF
Recall of veterinary medicinal product
Register of animal feed additives
Register of licences
Registration procedure for specific pets
Reporting a product defect
Reporting an adverse event
Requirements for importation (I)
Signal management
SPC, labelling and package leaflet veterinary medicinal products
Starting materials
Storage, transport and delivery of veterinary medicinal products
Submission of a dossier
Types of marketing authorisation
Union Product Database
Use of herbs in animals
Veterinary prescription